The accompanying consolidated financial statements, in the opinion of management, include all adjustments, consisting of normal recurring accruals, necessary for a fair presentation of the results for the interim periods presented.
For further information, refer to the consolidated financial statements and related notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2017.
The Company’s results for the three-month periods ended December 31, 2017 are not necessarily indicative of the results for the entire 2018 fiscal year.
References to the first quarters of 2018 and 2017 represent the fiscal quarters ended December 31, 2017 and 2016, respectively.
Compensation expense related to the restricted share awards was $1.1 million and $1.2 million for the three-month periods ended December 31, 2017 and 2016, respectively.
Compensation expense related to the non-employee director grants was $0.3 million and $0.2 million for the three-month periods ended December 31, 2017 and 2016, respectively.
The Company believes that the presentation of EBIT provides important supplemental information to investors to facilitate comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results.
The Credit Facility includes a $450 million revolving line of credit as well as provisions allowing for the increase of the facility commitment amount by an additional $250 million, if necessary, with the consent of the lenders.In the first quarter of 2018, sales, net earnings and diluted earnings per share were $173.5 million, $34.7 million and $1.33 per share, respectively, compared to $146.4 million, $10.7 million and $0.41 per share, respectively, in the first quarter of 2017.
The increase in net earnings and diluted earnings per share in the first quarter of 2018 as compared to the first quarter of 2017 was mainly due to the $25.1 million net tax benefit the Company recorded as a result of the Tax Cuts and Jobs Act that was signed into law on December 22, 2017.
Net sales increased $27.1 million, or 18.5%, to $173.5 million in the first quarter of 2018 from $146.4 million in the first quarter of 2017.
The increase in net sales in the first quarter of 2018 as compared to the first quarter of 2017 was due to a $20.2 million increase in the USG segment, a $3.7 million increase in the Test segment, a $2.0 million increase in the Technical Packaging segment and a $1.2 million increase in the Filtration segment.
In the first quarter of 2018, net sales of $37.5 million were $3.7 million, or 10.9%, higher than the $33.8 million recorded in the first quarter of 2017.
Net sales increased $20.2 million, or 56.8%, to $55.8 million in the first quarter of 2018 from $35.6 million in the first quarter of 2017.
The increase in the first quarter of 2018 compared to the first quarter of 2017 was mainly driven by the $19 million sales contribution from the NRG, Morgan Schaffer and Vanguard acquisitions and new products and software solutions at Doble.
In the first quarter of 2018, net sales of $20.2 million were $2.0 million, or 10.9% higher than the $18.2 million recorded in the first quarter of 2017.
The increase in the first quarter of 2018 compared to the first quarter of 2017 was mainly due to a $1.1 million increase in net sales at TEQ due to higher shipments to medical customers and a $0.9 million increase in net sales at Plastique.During the first quarter of 2018, the Company entered into three interest rate swaps with a notional amount of $150 million to hedge some of its exposure to variability in future LIBOR-based interest payments on variable rate debt.